INNOVATIVE PEDIATRIC ORAL FORMULATIONS FOR SECOND LINE TUBERCULOSIS DRUGS

NIH RePORTER · NIH · N44 · $1,499,998 · view on reporter.nih.gov ↗

Abstract

To develop pediatric formulations of tuberculosis therapeutics.

Key facts

NIH application ID
10497088
Project number
75N93021C00041-0-9999-1
Recipient
LUNA INNOVATIONS, INC.
Principal Investigator
NIKOLAI BRAUN
Activity code
N44
Funding institute
NIH
Fiscal year
2021
Award amount
$1,499,998
Award type
—
Project period
2021-09-03 → —